Karmanos Cancer Institute, Detroit is a clinical research site located in Detroit, Michigan, United States 48201.
Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.
Karmanos Cancer Institute, Detroit has participated in 5 clinical trials with 3 currently active.
Therapeutic areas: Invasive Mold Infections, Solid Tumor, High Grade Serous Ovarian Cancer.
Sponsors: Basilea Pharmaceutica, Mersana Therapeutics, Sanofi.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Michigan · View every site in Detroit
Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Karmanos Cancer Institute, Detroit has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Karmanos Cancer Institute, Detroit has 5 clinical trials on record, with 3 currently active. Their work covers Invasive Mold Infections, Solid Tumor, High Grade Serous Ovarian Cancer.
Karmanos Cancer Institute, Detroit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.